In this interview, CellVoyant founder and CEO Rafael Carazo Salas explores how AI, live-cell imaging, and stem cell technologies are converging to transform cell therapy development. He shares insights on the challenges of scaling living therapies, the role of predictive AI in clinical trials, and how spinning a biotech company out of academia can drive meaningful impact in the real world.
Let’s start with CellVoyant – what inspired you to launch the company, and how did…
Article Source
https://www.news-medical.net/news/20250416/CellVoyants-AI-Powered-Vision-for-the-Future-of-Cell-Therapy.aspx
